Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Acta cir. bras ; 31(6): 382-388, graf
Article in English | LILACS | ID: lil-785018

ABSTRACT

ABSTRACT PURPOSE: To investigate the regulatory roles of neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice. METHODS: To construct LPS-induced ALI mouse models, wild-type C57BL/6 mice were administered 5.0 mg/kg of LPS through endotracheal, and/or 1.0 mg/kg of ONO-5046, and/or 20.0 mg/kg of chemically modified tetracycline-3 (CMT-3) by gavage. The levels of MMP-9, tissue inhibitor of metalloprotease-1, interleukin (IL)-6 were detected by real time RT-PCR at 6 h, 24 h and 48 h, and tumor necrosis factor (TNF), lung wet-dry weight ratio, white blood cell (WBC) count and polymorphonuclear (PMN) count in bronchoalveolar lavage fluid (BALF) were tested at 48 h after administration. The 5-day survival analysis of the ALI mice was also performed. RESULTS: Both ONO-5046 and CMT-3, regardless of being used individually or combined, significantly reduced the levels of MMP-9, IL-6, and TNF in lung tissue as well as in BALF, and the WBC and PMN count in BALF. Combined treatment with ONO-5046 and CMT-3 remarkably improved the survival rate of ALI mice. CONCLUSION: Neutrophil elastase synergizes with matrix metalloproteinase-9 to promote and regulate the release of inflammatory mediators and the infiltration of inflammatory cells, consequently affecting the survival of lipopolysaccharide-induced acute lung injury mice.


Subject(s)
Animals , Sulfonamides/administration & dosage , Tetracyclines/administration & dosage , Leukocyte Elastase/metabolism , Matrix Metalloproteinase 9/metabolism , Acute Lung Injury/enzymology , Glycine/analogs & derivatives , Time Factors , Bronchoalveolar Lavage Fluid/cytology , Survival Analysis , Lipopolysaccharides , Interleukin-6/metabolism , Inflammation Mediators/metabolism , Leukocyte Elastase/drug effects , Tissue Inhibitor of Metalloproteinase-1/metabolism , Matrix Metalloproteinase 9/analysis , Matrix Metalloproteinase 9/drug effects , Tumor Necrosis Factors/metabolism , Disease Models, Animal , Acute Lung Injury/chemically induced , Acute Lung Injury/blood , Glycine/administration & dosage , Leukocyte Count , Mice, Inbred C57BL , Neutrophils
3.
The Korean Journal of Hepatology ; : 112-122, 2010.
Article in Korean | WPRIM | ID: wpr-14489

ABSTRACT

Infection of hepatitis B virus (HBV) is a main cause of liver diseases including hepatitis, cirrhosis and hepatocellular carcinoma (HCC). Among the HBV-encoded proteins, the HBV X protein (HBx) has been suspected to be strongly involved in HBV-associated liver pathogenesis. HBx, a virally encoded multifunctional regulator, has been shown to induce apoptosis, anti-apoptosis, proliferation, and transformation of cells depending on the cell lines, model systems used, assay protocols, and research groups. Among the several activities of HBx, the pro-apoptotic function of HBx will be discussed in this review. Given that the disruption of apoptosis pathway by HBx contributes to the liver pathogenesis, a better understanding of the molecular interference in the cellular pro-apoptotic networks by HBx will provide useful clues for the intervention in HBV-mediated liver diseases.


Subject(s)
Apoptosis , Hepatitis B/etiology , Liver Diseases/metabolism , Trans-Activators/metabolism , Tumor Necrosis Factors/metabolism , Tumor Suppressor Protein p53/metabolism
4.
Journal of Veterinary Science ; : 13-17, 2006.
Article in English | WPRIM | ID: wpr-36295

ABSTRACT

The phosphorylation of c-Jun NH (2)-terminal protein kinase (JNK), one of the mitogen-activated protein kinases, was analyzed in the sciatic nerves of Lewis rats with experimental autoimmune neuritis (EAN). Western blot analysis showed that the expression levels of both phosphorylated JNK1 (p-JNK1, approximately 46 kDa) and phosphorylated JNK2 (p-JNK2, approximately 54 kDa) in the sciatic nerves of rats with EAN increased significantly (p < 0.05) at day 14 post-immunization (PI) and remained at this level at days 24 and 30 PI, with a slight decrease. In EANaffected sciatic nerves, there was intense immunostaining for p-JNK in the infiltrating inflammatory cells (especially ED1- positive macrophages) and Schwann cells on days 14-24 PI, compared with those of controls. Some macrophages with increased p-JNK immunoreactivity was shown to be apoptotic, while some Schwann cells remained survived in this rat EAN model, suggesting that JNK is differentially involved in the EAN-affected sciatic nerves. These findings suggest that JNK phosphorylation is closely associated with the clearance of inflammatory cells as well as the activation of Schwann cells in the EAN affected sciatic nerves.


Subject(s)
Animals , Female , Rats , Apoptosis/physiology , Blotting, Western , Ectodysplasins , Immunohistochemistry , In Situ Nick-End Labeling , JNK Mitogen-Activated Protein Kinases/metabolism , Membrane Proteins/metabolism , Neuritis, Autoimmune, Experimental/enzymology , Phosphorylation , Rats, Inbred Lew , S100 Proteins/metabolism , Schwann Cells/metabolism , Sciatic Nerve/enzymology , Tumor Necrosis Factors/metabolism
5.
Experimental & Molecular Medicine ; : 401-407, 2006.
Article in English | WPRIM | ID: wpr-53150

ABSTRACT

Although the apoptosis of chondrocytes plays an important role in endochondral ossification, its mechanism has not been elucidated. In this study, we show that guanosine induces chondrocyte apoptosis based on the results of acridine orange/ ethidium bromide staining, caspase-3 activation, and sub-G1 fraction analysis. The potent inhibitory effect of dipyridamole, a nucleoside transporter blocker, indicates that extracellular guanosine must enter the chondrocytes to induce apoptosis. We found that guanosine promotes Fas-Fas ligand interaction which, in turn, leads to chondrocyte apoptosis. These findings indicate a novel mechanism for endochondral ossification via metabolic regulation.


Subject(s)
Rats , Animals , Tumor Necrosis Factors/metabolism , Signal Transduction/drug effects , Receptors, Tumor Necrosis Factor/metabolism , Rats, Sprague-Dawley , Nucleoside Transport Proteins/metabolism , Membrane Glycoproteins/metabolism , Guanosine/pharmacology , Fas Ligand Protein , Chondrocytes/drug effects , Apoptosis/drug effects , fas Receptor
6.
Journal of Korean Medical Science ; : 770-776, 2005.
Article in English | WPRIM | ID: wpr-176549

ABSTRACT

Lack of surface Fas expression is a main route for apoptotic resistance which is considered an important mechanism of tumorigenesis and tumor progression. Fas and FasL expressions in 110 non-small cell lung carcinomas (NSCLCs) were investigated to evaluate their roles in pulmonary carcinogenesis and to examine the clinicopathologic significance of Fas expression with its relationship with p53 and bcl-2 overexpressions. Immunohistochemical analysis using tissue microarray demonstrated that a large proportion of NSCLC patients (60%) showed lack of membranous Fas expression. The Fas-negative cases revealed the significantly lower survival rate than Fas-positive ones. Also, the loss of Fas receptor expression was found more frequently in advanced stage and higher nodal status. FasL protein was increased in most NSCLCs (89%) compared to normal lungs. p53 and bcl-2 overexpressions showed no association with Fas expression. Conclusively, reduced membranous Fas expression as a mechanism of apoptotic resistance is considered to play an important part of the pulmonary carcinogenesis, which may predict poor survival and have a bad prognostic influence. Increased FasL expression is thought to be a basis for the immune evasion in NSCLCs. The rare bcl-2 overexpression suggests that this anti-apoptotic protein is unlikely to play a role in the apoptotic resistance of NSCLCs.


Subject(s)
Female , Humans , Male , Middle Aged , fas Receptor/metabolism , Apoptosis , Carcinoma, Non-Small-Cell Lung/metabolism , Cell Survival , Comparative Study , Gene Expression Profiling , Gene Expression Regulation, Neoplastic , Korea/epidemiology , Lung Neoplasms/metabolism , Membrane Glycoproteins/metabolism , Oligonucleotide Array Sequence Analysis , Prognosis , Proto-Oncogene Proteins c-bcl-2/metabolism , Risk Assessment/methods , Risk Factors , Survival Analysis , Survival Rate , Biomarkers, Tumor/metabolism , Tumor Necrosis Factors/metabolism , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL